InGeneron

InGeneron Summary Financials People Technology Signals & News About InGeneron enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells. Houston, Texas, United States 11-50 Series D Private www.ingeneron.com/ 38,648 Highlights Total Funding Amount $51M Number of Current Team Members 2 Number of Investors 1 Recent News & Activity News • Oct 31, 2019 Bio Portfolio — InGeneron Announces Publication of Preclinical Results for its Cell Therapy in Chronic Ischemic Heart Failure Funding Round • Jun 11, 2019 InGeneron raised $23,000,000 / Series D from Sanford Health Discover more funding rounds News • Jun 11, 2019 Xconomy — InGeneron Adds $23M to Test Stem Cell Therapy for Rotator Cuff Tears VIEW ALL Details Industries Alternative Medicine Biotechnology Health Care Therapeutics Headquarters Regions Greater Houston Area, Southern US Founded Date 2006 Founders Eckhard Alt Operating Status Active Last Funding Type Series D Legal Name InGeneron, Inc. Company Type For Profit Contact Email contact@ingeneron.com Phone Number (713)440-9900 InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Its system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells. Founded in 2006, we are a Houston-headquartered,privately held company that was formed to innovate cell-based technologies for health care and life science research. The work of our scientists and doctors in the field of the stem and regenerative cell research has enabled us to develop a regenerative cell therapy product platform for multiple potential applications. This work has yielded numerous peer-reviewed publications and studies on the use of autologous adult stem cells – those that are extracted from and reintroduced into the same person – to promote healing.